臨牀透析 Vol.14 No.4(2-3)


特集名 Uremic Toxins
題名 各論 (3) AGEs
発刊年月 1998年 04月
著者 前田 憲志 名古屋大学大幸医療センター内科
【 要旨 】 生体内でadvanced glycation end products (AGEs)としてcarboxymethyllysine (CML),pyrraline,pentosidine,crossline,imidazolone,glyoxal dimer (GOLD),methylglyoxal dimer (MOLD)が認められている.AGEsの産生は3-deoxyglucosone(3-DG),glyoxal,methylglyoxalなどの中間物質によって加速される.腎不全では血清AGEs濃度は著明に増加し,走化性やサイトカインの産生亢進,破骨細胞を活性化するなどの生物活性が認められる.慢性毒性を有するuremic toxinsとして重要である.
Theme Uremic Toxins
Title Advanced glycation end products
Author Kenji Maeda Nagoya University Daiko Medical Center
[ Summary ] Carboxy methyl lysine, pyrraline, pentosidine, crossline, imidazolone, glyoxal dimer and methyl glyoxal dimer are AGES which have been identified in uremic patients. Production of AGES is accelerated with active intermediates such as 3-deoxy-glucosone, glyoxal and methylglyoxal.
The concentration of AGES increases markedly in uremic patients. Directed migration (chemotaxis) and random cell migration (chemokinesis) activities of human monocytes to AGES have been observed. AGES increased the secretion of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 from macrophages. Cumulative studies have suggested that AGES are important chronic-reactive uremic toxins.
戻る